Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ Industry / Manufacturing/  India's Hetero wins emergency use nod to make Roche's Covid drug
BackBack

India's Hetero wins emergency use nod to make Roche's Covid drug

Indian drug developer Hetero said that it has received emergency use approval to make a generic version of Roche Holding AG's COVID-19 drug

A sign at a diagnostics site for Swiss pharmaceutical giant Roche. (REUTERS)Premium
A sign at a diagnostics site for Swiss pharmaceutical giant Roche. (REUTERS)

BENGALURU: Indian drug developer Hetero said on Monday that it has received emergency use approval from the country's health authorities to make a generic version of Roche Holding AG's COVID-19 drug.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.

Catch all the Industry News, Banking News and Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Published: 06 Sep 2021, 01:31 PM IST
Next Story footLogo
Recommended For You
Manufacturing Stocks
₹557.550.52%
ITC
₹4280.13%
₹2,987.85-0.37%
₹152.852%
Switch to the Mint app for fast and personalized news - Get App